- Experience. Mayo Clinic is a leading treatment center for people with primary sclerosing cholangitis. Each year since 2010, Mayo Clinic specialists have cared for more than 1,600 patients with cholangitis, many of whom had primary sclerosing cholangitis or associated complications.
- Nationally recognized expertise. Liver specialists at Mayo Clinic have developed several mathematical models that assess the severity of certain liver diseases. These models help doctors determine where a person ranks on the priority list for a transplant.
- Pioneers in research. Many Mayo Clinic doctors are involved in clinical trials of new medications for primary sclerosing cholangitis. Researchers at Mayo Clinic are also studying the DNA of people with primary sclerosing cholangitis in hopes of identifying genes that increase the risk of the disease and predict its course.
Liver transplant. Mayo Clinic transplant specialists have performed many transplants in people who have primary sclerosing cholangitis. People with primary sclerosing cholangitis who have liver transplants generally have high survival rates — 80 to 85 percent after five years on average. Recipients of liver transplants at Mayo Clinic have above-average survival rates.
Mayo Clinic is also one of the few medical centers in the country to offer liver transplants as a treatment option for bile duct cancer, which develops at much higher rates among people with primary sclerosing cholangitis than in the general population.
Mayo Clinic in Rochester, Minn., ranks No. 1 for digestive disorders in the U.S. News & World Report Best Hospitals rankings. Mayo Clinic in Scottsdale, Ariz., and Mayo Clinic in Jacksonville, Fla., are ranked among the Best Hospitals for digestive disorders by U.S. News & World Report. Mayo Clinic also ranks among the Best Children's Hospitals for digestive disorders.
Learn more about the Liver Transplant Program's expertise and rankings.